Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Spironolactone × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Genitourinary 1 Breast 1

Conditions

Neoplasms 1 Critical Illness 1 Acute Kidney Injury 1

Interventions

pembrolizumab 24 Docetaxel 19 Gemcitabine 15 Paclitaxel 13 Prednisone 11 Nivolumab 11 pazopanib 10 Sorafenib 9 Radiotherapy 9 Therapeutics 7 Leuprolide 7 Ipilimumab 7 Cyclophosphamide 7 Cisplatin 7 Carboplatin 7 Blood Specimen Collection 7 Bevacizumab 7 avelumab 6 atezolizumab 6 Thalidomide 6 Sunitinib 6 Radiation 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 Standard of Care 5 Radiosurgery 5 Denosumab 5 temsirolimus 4 padeliporfin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡